Implications of ejection fraction value for trastuzumab.
Schlosshan
D
D
Dickinson
C
C
Sapsford
R
R
Dodwell
D
D
Perren
T
T
D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology*; D006801:Humans; D013318:Stroke Volume / Q000187:drug effects*; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab